06.01.2026 • News

Arkema and Praana Announce Proposed Transaction in Plastic Additives

Arkema and Praana Group announced that they have entered into a proposed transaction under which Praana would acquire selected plastic additives businesses from Arkema.

The contemplated transaction covers Arkema’s global Methyl Methacrylate Butadiene Styrene (MBS) copolymers business as well as its European and Asian acrylic impact modifier and processing aids (AIMPA) activities, currently reported within Arkema’s Coating Solutions segment. These activities generated sales of approximately €44 million in 2024 and supply additives that enhance impact resistance and improve the productivity of extrusion and molding processes for PVC profiles, pipes, packaging and various composite materials, particularly in construction and packaging markets.

As part of the proposed transaction, the Vlissingen production facility in the Netherlands, employing around 50 people, would be transferred to Praana. Arkema would retain its Mobile, Alabama, site in the United States, along with all of its American AIMPA business, which would remain within the group’s existing portfolio.

Arkemas Vlissingen site.
Arkema's Vlissingen site.
© Arkema

The Indian group Praana is a leading producer of specialty chemicals and composite materials comprising Sterling Specialty Chemicals, Galata Chemicals, Artek Surfin Chemicals, and 3B Fibreglass, which offer advanced solutions for the construction, textile, automotive, cleaning and personal care products industries as well as various industrial markets. Upon completion, the acquired plastic additives businesses will form part of Galata Chemicals, Praana Group’s specialty additives platform.

Vishal Goenka, Vice Chairman of Praana Group, commented, “This proposed acquisition strengthens Galata Chemicals’ portfolio with complementary plastic additives technologies that enhance impact performance and process efficiency in PVC and composite applications. It supports integration-led growth, deeper customer engagement, and scalable value creation across core end markets.”

This proposed divestment is expected to be finalized in the first quarter of 2026 and is subject to a preliminary information and consultation process involving the employee representative bodies in the Netherlands.

Company

Logo:

Arkema

420 rue d’Estienne d’Orves
92705 Colombes Cedex
France

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read